{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:29:22Z","timestamp":1790400562624,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T00:00:00Z","timestamp":1465344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T00:00:00Z","timestamp":1465344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genomic Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Targeted next-generation sequencing (NGS) identified a novel loss of function mutation in <jats:italic>GARS<\/jats:italic>, a gene linked to Charcot\u2013Marie\u2013Tooth disease (CMT), in a paediatric acute lymphoblastic leukaemia patient with severe chemotherapy-induced peripheral neuropathy (CIPN) due to vincristine. The patient was clinically asymptomatic, and lacked a family history of neuropathy. The effect of the mutation was modelled in a zebrafish knockdown system that recapitulated the symptoms of the patient both prior to and after treatment with vincristine. Confocal microscopy of pre- and post-synaptic markers revealed that the GARS knockdown results in changes to peripheral motor neurons, acetylcholine receptors and their co-localisation in neuromuscular junctions (NMJs), whereas a sensitive and reproducible stimulus\u2013response assay demonstrated that the changes correlating with the GARS mutation in themselves fail to produce peripheral neuropathy symptoms. However, with vincristine treatment the GARS knockdown exacerbates decreased stimulus response and NMJ lesions. We propose that there is substantial benefit in the use of a targeted NGS screen of cancer patients who are to be treated with microtubule targeting agents for deleterious mutations in CMT linked genes, and for the screening in zebrafish of reagents that might inhibit CIPN.<\/jats:p>","DOI":"10.1038\/npjgenmed.2016.16","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T12:25:31Z","timestamp":1465388731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An asymptomatic mutation complicating severe chemotherapy-induced peripheral neuropathy (CIPN): a case for personalised medicine and a zebrafish model of CIPN"],"prefix":"10.1038","volume":"1","author":[{"given":"Michael P","family":"Holloway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D","family":"DeNardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanika","family":"Phornphutkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colby","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Richendrfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"Creton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A","family":"Altura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"BFnpjgenmed201616_CR1","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"C-H Pui","year":"2008","unstructured":"Pui, C.-H., Robison, L. & Look, A. Acute lymphoblastic leukaemia. Lancet 371, 1030\u20131043 (2008).","journal-title":"Lancet"},{"key":"BFnpjgenmed201616_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.0.CO;2-U","volume":"18","author":"A Jordan","year":"1998","unstructured":"Jordan, A., Hadfield, J. A. & Lawrence, N. J. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med. Res. Rev. 18, 259\u2013296 (1998).","journal-title":"Med. Res. Rev."},{"key":"BFnpjgenmed201616_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2008.01.008","volume":"66","author":"AA Argyriou","year":"2008","unstructured":"Argyriou, A. A., Koltzenburg, M., Polychronopoulos, P., Papapetropoulos, S. & Kalofonos, H. P. Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit. Rev. Oncol. Hematol. 66, 218\u2013228 (2008).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFnpjgenmed201616_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/bmj.324.7335.466","volume":"324","author":"RA Hughes","year":"2002","unstructured":"Hughes, R. A. Peripheral neuropathy. Br. Med. J. 324, 466\u2013469 (2002).","journal-title":"Br. Med. J."},{"key":"BFnpjgenmed201616_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/PL00007853","volume":"249","author":"S Quasthoff","year":"2002","unstructured":"Quasthoff, S. & Hartung, H. P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 249, 9\u201317 (2002).","journal-title":"J. Neurol."},{"key":"BFnpjgenmed201616_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00043426-200304000-00010","volume":"25","author":"C Allen","year":"2003","unstructured":"Allen, C. et al. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: A Pediatric Oncology Group Study. J. Pediatr. Hematol. Oncol. 25, 316\u2013320 (2003).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"BFnpjgenmed201616_CR7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.neuro.2008.05.003","volume":"29","author":"S Tarlaci","year":"2008","unstructured":"Tarlaci, S. Vincristine-induced fatal neuropathy in non-Hodgkin\u2019s lymphoma. Neurotoxicology 29, 748\u2013749 (2008).","journal-title":"Neurotoxicology"},{"key":"BFnpjgenmed201616_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuro.2013.05.008","volume":"37","author":"NE LaPointe","year":"2013","unstructured":"LaPointe, N. E. et al. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. Neurotoxicology 37, 231\u2013239 (2013).","journal-title":"Neurotoxicology"},{"key":"BFnpjgenmed201616_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnen\/59.7.599","volume":"59","author":"MS Wang","year":"2000","unstructured":"Wang, M. S., Wu, Y., Culver, D. G. & Glass, J. D. Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy. J. Neuropathol. Exp. Neurol. 59, 599\u2013606 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnpjgenmed201616_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jns.2014.10.013","volume":"347","author":"M Tazir","year":"2014","unstructured":"Tazir, M., Hamadouche, T., Nouioua, S., Mathis, S. & Vallat, J.-M. M. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: An update. J. Neurol. Sci. 347, 14\u201322 (2014).","journal-title":"J. Neurol. Sci."},{"key":"BFnpjgenmed201616_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00043426-200304000-00010","volume":"25","author":"AR Chauvenet","year":"2003","unstructured":"Chauvenet, A. R. et al. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J. Pediatr. Hematol. Oncol. 25, 316\u2013320 (2003).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"BFnpjgenmed201616_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1365-2141.2001.03126.x","volume":"115","author":"R Naumann","year":"2001","unstructured":"Naumann, R. et al. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life\u2010threatening vincristine neurotoxicity. Br. J. Haematol. 115, 323\u2013325 (2001).","journal-title":"Br. J. Haematol."},{"key":"BFnpjgenmed201616_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2015.06.056","volume":"357","author":"GK Boora","year":"2015","unstructured":"Boora, G. K. et al. Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance). J. Neurol. Sci. 357, 35\u201340 (2015).","journal-title":"J. Neurol. Sci."},{"key":"BFnpjgenmed201616_CR14","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1212\/01.wnl.0000201275.18875.ac","volume":"66","author":"R Del Bo","year":"2006","unstructured":"Del Bo, R. Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology 66, 752\u2013754 (2006).","journal-title":"Neurology"},{"key":"BFnpjgenmed201616_CR15","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1093\/brain\/awh590","volume":"128","author":"K Sivakumar","year":"2005","unstructured":"Sivakumar, K. et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 128, 2304\u20132314 (2005).","journal-title":"Brain"},{"key":"BFnpjgenmed201616_CR16","doi-asserted-by":"publisher","first-page":"11239","DOI":"10.1073\/pnas.0705055104","volume":"104","author":"LA Nangle","year":"2007","unstructured":"Nangle, L. A., Zhang, W., Xie, W., Yang, X.-L. L. & Schimmel, P. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc. Natl Acad. Sci. USA 104, 11239\u201311244 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnpjgenmed201616_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neuron.2006.08.027","volume":"51","author":"KL Seburn","year":"2006","unstructured":"Seburn, K. L., Nangle, L. A., Cox, G. A., Schimmel, P. & Burgess, R. W. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 51, 715\u2013726 (2006).","journal-title":"Neuron"},{"key":"BFnpjgenmed201616_CR18","doi-asserted-by":"publisher","first-page":"e1002399","DOI":"10.1371\/journal.pgen.1002399","volume":"7","author":"WW Motley","year":"2011","unstructured":"Motley, W. W. et al. Charcot-Marie-Tooth-Linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. Plos Genet. 7, e1002399 (2011).","journal-title":"Plos Genet."},{"key":"BFnpjgenmed201616_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nchembio.307","volume":"6","author":"D Kokel","year":"2010","unstructured":"Kokel, D. et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat. Chem. Biol. 6, 231\u2013237 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"BFnpjgenmed201616_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-385975-4.00007-3","volume":"97","author":"A Raphael","year":"2011","unstructured":"Raphael, A. & Talbot, W. New insights into signaling during myelination in zebrafish. Curr. Top. Dev. Biol. 97, 1\u201319 (2011).","journal-title":"Curr. Top. Dev. Biol."},{"key":"BFnpjgenmed201616_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pneurobio.2014.03.001","volume":"118","author":"PJ Babin","year":"2014","unstructured":"Babin, P. J., Goizet, C. & Rald\u00faa, D. Zebrafish models of human motor neuron diseases: advantages and limitations. Prog. Neurobiol. 118, 36\u201358 (2014).","journal-title":"Prog. Neurobiol."},{"key":"BFnpjgenmed201616_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.vascn.2008.01.004","volume":"57","author":"MJ Winter","year":"2008","unstructured":"Winter, M. J. et al. Validation of a larval zebrafish locomoter assay for assessing the seizure liability of early-stage development drugs. J. Pharmacol. Toxicol. Methods 57, 176\u2013187 (2008).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"BFnpjgenmed201616_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1529-8027.2012.00371.x","volume":"17","author":"TM Khan","year":"2112","unstructured":"Khan, T. M. et al. Vincristine and bortezomib cause axon outgrowth and behavioral defects in larval zebrafish. J. Peripher. Nerv. Syst. 17, 76\u201389 (2112).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"BFnpjgenmed201616_CR24","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1093\/hmg\/ddp310","volume":"18","author":"K-LL Boon","year":"2009","unstructured":"Boon, K.-L. L. et al. Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Hum. Mol. Genet. 18, 3615\u20133625 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnpjgenmed201616_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ydbio.2005.06.027","volume":"285","author":"JA Panzer","year":"2005","unstructured":"Panzer, J. A., Gibbs, S. M., Dosch, R. & Wagner, D. Neuromuscular synaptogenesis in wild-type and mutant zebrafish. Dev. Biol. 285, 340\u2013357 (2005).","journal-title":"Dev. Biol."},{"key":"BFnpjgenmed201616_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1515\/rns.2011.008","volume":"22","author":"R Colwill","year":"2011","unstructured":"Colwill, R. & Creton, R. Imaging escape and avoidance behavior in zebrafish larvae. Rev. Neurosci. 22, 63\u201373 (2011).","journal-title":"Rev. Neurosci."},{"key":"BFnpjgenmed201616_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbr.2011.04.033","volume":"223","author":"S Pelkowski","year":"2011","unstructured":"Pelkowski, S. et al. A novel high-throughput imaging system for automated analyses of avoidance behavior in zebrafish larvae. Behav. Brain Res. 223, 135\u2013144 (2011).","journal-title":"Behav. Brain Res."},{"key":"BFnpjgenmed201616_CR28","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1074\/jbc.R100052200","volume":"277","author":"TC Sudhof","year":"2002","unstructured":"Sudhof, T. C. Synaptotagmins: why so many? J. Biol. Chem. 277, 7629\u20137632 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnpjgenmed201616_CR29","doi-asserted-by":"publisher","first-page":"e67276","DOI":"10.1371\/journal.pone.0067276","volume":"8","author":"A Chapman","year":"2013","unstructured":"Chapman, A., Bennett, E., Ramesh, T., Vos, K. & Grierson, A. Axonal transport defects in a mitofusin 2 loss of function model of Charcot-Marie-Tooth disease in zebrafish. PLoS ONE 8, e67276 (2013).","journal-title":"PLoS ONE"},{"key":"BFnpjgenmed201616_CR30","doi-asserted-by":"publisher","first-page":"13906","DOI":"10.1073\/pnas.1008598107","volume":"107","author":"H Wen","year":"2010","unstructured":"Wen, H. et al. Distinct roles for two synaptotagmin isoforms in synchronous and asynchronous transmitter release at zebrafish neuromuscular junction. Proc. Natl Acad. Sci. USA 107, 13906\u201313911 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnpjgenmed201616_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/dev.420070109","volume":"7","author":"CB Kimmel","year":"1974","unstructured":"Kimmel, C. B., Patterson, J. & Kimmel, R. O. The development and behavioral characteristics of the startle response in the zebrafish. Dev. Psychobiol. 7, 47\u201360 (1974).","journal-title":"Dev. Psychobiol."},{"key":"BFnpjgenmed201616_CR32","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1523\/JNEUROSCI.4003-12.2013","volume":"33","author":"GA Armstrong","year":"2013","unstructured":"Armstrong, G. A. & Drapeau, P. Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS. J. Neurosci. 33, 1741\u20131749 (2013).","journal-title":"J. Neurosci."},{"key":"BFnpjgenmed201616_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/oxfordjournals.annonc.a059220","volume":"6","author":"TJ Postma","year":"1995","unstructured":"Postma, T. J. et al. Paclitaxel-induced Neuropathy. Ann. Oncol. 6, 489\u2013494 (1995).","journal-title":"Ann. Oncol."},{"key":"BFnpjgenmed201616_CR34","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1523\/JNEUROSCI.4065-10.2011","volume":"31","author":"S Barrrientos","year":"2011","unstructured":"Barrrientos, S. et al. Axonal degeneration is mediated by the mitochondrial permeability transition pore. J. Neurosci. 31, 966\u2013978 (2011).","journal-title":"J. Neurosci."},{"key":"BFnpjgenmed201616_CR35","doi-asserted-by":"publisher","first-page":"9552","DOI":"10.1073\/pnas.90.20.9552","volume":"90","author":"MA Jordan","year":"1993","unstructured":"Jordan, M. A., Toso, R. J., Thrower, D. & Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl Acad. Sci. USA 90, 9552\u20139556 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnpjgenmed201616_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ana.22166","volume":"69","author":"AS Saporta","year":"2011","unstructured":"Saporta, A. S. et al. (2011). Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann. Neurol. 69, 22\u201333 (2011).","journal-title":"Ann. Neurol."},{"key":"BFnpjgenmed201616_CR37","doi-asserted-by":"publisher","first-page":"10397","DOI":"10.1523\/JNEUROSCI.1671-06.2006","volume":"26","author":"A Antonellis","year":"2006","unstructured":"Antonellis, A. et al. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. J. Neurosci. 26, 10397\u201310406 (2006).","journal-title":"J. Neurosci."},{"key":"BFnpjgenmed201616_CR38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/35097557","volume":"2","author":"JR Sanes","year":"2001","unstructured":"Sanes, J. R. & Lichtman, J. W. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat. Rev. Neurosci. 2, 791\u2013805 (2001).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnpjgenmed201616_CR39","doi-asserted-by":"publisher","first-page":"iv45","DOI":"10.1093\/neuonc\/nos203","volume":"14","author":"W Grisold","year":"2012","unstructured":"Grisold, W., Cavaletti, G. & Windebank, A. J. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro. Oncol. 14, iv45\u2013iv54 (2012).","journal-title":"Neuro. Oncol."},{"key":"BFnpjgenmed201616_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1188\/07.CJON.361-376","volume":"11","author":"R Wickham","year":"2007","unstructured":"Wickham, R. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice. Clin. J. Oncol. Nurs. 11, 361\u2013376 (2007).","journal-title":"Clin. J. Oncol. Nurs."},{"key":"BFnpjgenmed201616_CR41","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1158\/1078-0432.CCR-15-0407","volume":"21","author":"JN McCutcheon","year":"2007","unstructured":"McCutcheon, J. N. & Giaccone, G. Next-Generation Sequencing: Targeting Targeted Therapies. [Published on-line ahead of print April 6, 2015]. Clin. Cancer Res. 21, 3584\u20133585 (2007).","journal-title":"Clin. Cancer Res."},{"key":"BFnpjgenmed201616_CR42","doi-asserted-by":"publisher","first-page":"283ra53","DOI":"10.1126\/scitranslmed.aaa7161","volume":"7","author":"S Jones","year":"2015","unstructured":"Jones, S. et al. Personalized genomic analyses for cancer mutation discovery and interpretation. Sci. Transl. Med. 7, 283ra53 (2015).","journal-title":"Sci. Transl. Med."},{"key":"BFnpjgenmed201616_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ana.24265","volume":"76","author":"AS Beutler","year":"2014","unstructured":"Beutler, A. S. et al. Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy. Ann. Neurol. 76, 727\u2013737 (2014).","journal-title":"Ann. Neurol."},{"key":"BFnpjgenmed201616_CR44","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1242\/dev.038711","volume":"137","author":"H Wu","year":"2010","unstructured":"Wu, H., Xiong, W. C. & Mei, L. To build a synapse: signaling pathways in neuromuscular junction assembly. Development 137, 1017\u20131033 (2010).","journal-title":"Development"},{"key":"BFnpjgenmed201616_CR45","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.3892\/mmr.2014.3047","volume":"11","author":"YB Hong","year":"2015","unstructured":"Hong, Y. B. et al. A family with axonal sensorimotor polyneuropathy with TUBB3 mutation. Mol. Med. Rep. 11, 2729\u20132734 (2015).","journal-title":"Mol. Med. Rep."},{"key":"BFnpjgenmed201616_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan, MA. & Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253\u2013265 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnpjgenmed201616_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2013","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2013).","journal-title":"Nat. Methods"},{"key":"BFnpjgenmed201616_CR48","first-page":"e50622","volume":"77","author":"H Richendrfer","year":"2013","unstructured":"Richendrfer, H. & Creton, R. Automated high-throughput behavioral analyses in zebrafish larvae. J. Vis. Exp. 77, e50622 (2013).","journal-title":"J. Vis. Exp."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjgenmed201616.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjgenmed201616","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjgenmed201616.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T12:28:20Z","timestamp":1672835300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjgenmed201616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,30]]}},"alternative-id":["BFnpjgenmed201616"],"URL":"https:\/\/doi.org\/10.1038\/npjgenmed.2016.16","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]},"assertion":[{"value":"27 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16016"}}